Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Marsh & McLennan Companies, Inc. (MMC) Stock Forecast & Price Prediction United States | NYSE | Financial Services | Insurance Brokers
$175.80
-6.77 (-3.71%)Did MMC Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Marsh & McLennan is one of their latest high-conviction picks.
Based on our analysis of 28 Wall Street analysts, MMC has a neutral consensus with a median price target of $206.00 (ranging from $174.00 to $258.00). The overall analyst rating is Buy (7.0/10). Currently trading at $175.80, the median forecast implies a 17.2% upside. This outlook is supported by 8 Buy, 14 Hold, and 1 Sell ratings.
The most optimistic forecast comes from Brian Meredith at UBS, projecting a 46.8% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for MMC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 14, 2026 | Cantor Fitzgerald | Ryan Tunis | Overweight | Maintains | $208.00 |
| Jan 13, 2026 | Wells Fargo | Elyse Greenspan | Equal-Weight | Maintains | $199.00 |
| Jan 8, 2026 | Barclays | Alex Scott | Overweight | Maintains | $210.00 |
| Jan 7, 2026 | JP Morgan | Jimmy Bhullar | Overweight | Maintains | $226.00 |
| Jan 7, 2026 | Evercore ISI Group | David Motemaden | Outperform | Maintains | $236.00 |
| Jan 6, 2026 | Keefe, Bruyette & Woods | Meyer Shields | Market Perform | Maintains | $205.00 |
| Dec 16, 2025 | Mizuho | Yaron Kinar | Outperform | Initiates | $212.00 |
| Dec 4, 2025 | Citigroup | Matthew Heimermann | Neutral | Maintains | $201.00 |
| Nov 20, 2025 | Barclays | Alex Scott | Overweight | Upgrade | $206.00 |
| Nov 3, 2025 | TD Cowen | Andrew Kligerman | Hold | Maintains | $200.00 |
| Nov 3, 2025 | B of A Securities | Joshua Shanker | Underperform | Downgrade | $181.00 |
| Oct 20, 2025 | Goldman Sachs | Robert Cox | Neutral | Upgrade | $195.00 |
| Oct 17, 2025 | Wells Fargo | Elyse Greenspan | Equal-Weight | Maintains | $212.00 |
| Oct 17, 2025 | Evercore ISI Group | David Motemaden | Outperform | Maintains | $237.00 |
| Oct 17, 2025 | Keefe, Bruyette & Woods | Meyer Shields | Market Perform | Upgrade | $191.00 |
| Oct 9, 2025 | JP Morgan | Jimmy Bhullar | Overweight | Upgrade | $242.00 |
| Oct 8, 2025 | Barclays | Alex Scott | Equal-Weight | Maintains | $221.00 |
| Oct 8, 2025 | Wells Fargo | Elyse Greenspan | Equal-Weight | Maintains | $222.00 |
| Oct 8, 2025 | UBS | Brian Meredith | Buy | Maintains | $257.00 |
| Oct 7, 2025 | Morgan Stanley | Michael Phillips | Equal-Weight | Maintains | $215.00 |
The following stocks are similar to Marsh & McLennan based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Marsh & McLennan Companies, Inc. has a market capitalization of $86.43B with a P/E ratio of 21.9x. The company generates $26.45B in trailing twelve-month revenue with a 15.6% profit margin.
Revenue growth is +11.5% quarter-over-quarter, while maintaining an operating margin of +19.2% and return on equity of +28.7%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Global leader in risk management and consulting.
The company operates through two main segments: Risk & Insurance Services and Consulting. It generates revenue by providing insurance broking, reinsurance, and consulting services to a diverse range of clients, helping them manage risks and optimize operations.
Marsh & McLennan is recognized for its strategic advice and solutions that facilitate effective decision-making. In 2025, the company reported strong revenue growth due to performance across all divisions and strategic acquisitions, highlighting its market significance and ability to navigate complex business risks.
Financial Services
Insurance Brokers
90,000
Mr. John Quinlan Doyle
United States
1987
Hyperscale companies are utilizing private credit and debt markets to fund AI data center expansions, presenting potential risks and rewards for insurers and lenders.
The rise of private credit for AI data centers signals potential growth in tech investments, impacting risk assessments and opportunities for insurers and lenders.
"Halftime Report" traders have shared their top stock picks to monitor for the second half of the year, providing insights for potential investment opportunities.
Top stock recommendations can signal emerging trends and potential growth opportunities, influencing investment strategies and portfolio adjustments.
Based on our analysis of 28 Wall Street analysts, Marsh & McLennan Companies, Inc. (MMC) has a median price target of $206.00. The highest price target is $258.00 and the lowest is $174.00.
According to current analyst ratings, MMC has 8 Buy ratings, 14 Hold ratings, and 1 Sell ratings. The stock is currently trading at $175.80. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict MMC stock could reach $206.00 in the next 12 months. This represents a 17.2% increase from the current price of $175.80. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company operates through two main segments: Risk & Insurance Services and Consulting. It generates revenue by providing insurance broking, reinsurance, and consulting services to a diverse range of clients, helping them manage risks and optimize operations.
The highest price target for MMC is $258.00 from Brian Meredith at UBS, which represents a 46.8% increase from the current price of $175.80.
The lowest price target for MMC is $174.00 from at , which represents a -1.0% decrease from the current price of $175.80.
The overall analyst consensus for MMC is neutral. Out of 28 Wall Street analysts, 8 rate it as Buy, 14 as Hold, and 1 as Sell, with a median price target of $206.00.
Stock price projections, including those for Marsh & McLennan Companies, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.